Carcinoembryonic Antigen Market Analysis 2019 Key News by Top Companies with Latest Technology, Developments, Revenue, Size and Industry Growth Insights to 2025
Industry Report “Digital Commerce Platform Market” provides
a clear picture of the Current Market Scenario which includes past and
estimated future size with respect to value and volume, technological
advancement, macro economical and governing factors in the Digital Commerce Platform
market.
Carcinoembryonic
Antigen Market Highlights
Carcinoembryogenic antigen (CEA) is a group of glycoproteins
which are produced during the fetal developmental stages by gastrointestinal
tissues. CEA is responsible for cell adhesion. Healthy adults do not have CEA
concentrations. However, smoking and certain medical conditions such as
colorectal cancer, breast cancer etc. can mark the presence of CEA in the body.
Thus, CEA based diagnostic assays are used for the detection of such cancers
and to check the treatment efficiency during the therapeutic period by a
physician.
Regional
Analysis
The
Americas account for the largest share in the carcinoembryogenic antigen
market. The Americas mainly include countries like the U.S. and Canada.
Increasing prevalence of cancer and high healthcare expenditures within the
region will boost the market growth over the assessment period.
Europe
is the second highest revenue generating region in the global
carcinoembryogenic antigen market. Increasing prevalence of cancer, fast
adoption of new technologies and presence of developed countries like Germany
and U.K within the region will boost the market growth during the forecasted
period.
On
account of the developing medical infrastructure, rising healthcare
expenditure, and increasing government initiatives, Asia Pacific region is
expected to grow the fastest.
The
Middle East & Africa is expected to grow slower than the global average.
The Middle Eastern countries, for instance, UAE and Saudi Arabia dominates the
market due to high income and the government support to improve public health.
Taste
the market data and market information presented through more than 50 market
data tables and figures spread over 80 pages of the project report. Avail the
in-depth table of content (TOC) & market synopsis on “Global
Carcinoembryogenic Antigen Market” Research Report – Forecast till 2023.
Segmentation
The
global carcinoembryonic antigen market has been segmented on the basis of
application, sampling, and end user.
Based
on application, the market has been segmented into colorectal, pancreatic,
breast, lung cancer, and others.
Based
on sampling, the market has been segmented into antecubital, peritoneal,
pleural, serebrospinal, and others.
Based
on the end users, the market has been segmented into hospitals, diagnostic
centers, research centers, and others.
Global
Carcinoembryonic Antigen Market Research Report: Information by Application
(Colorectal Cancer, Pancreatic Cancer, Breast Cancer, Lung Cancer, and Others),
End User (Hospitals and Clinics, Diagnostic Centers, and Others), and Region
(the Americas, Europe, Asia-Pacific, and the Middle East & Africa)—Forecast
till 2025 @
Market
Players
Some
of key players profiled in the report are Lee BioSolutions, F.
Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated., Correlogic Systems,
Inc, Genway Biotech, Inc., Abbott., RayBiotech, Inc., Abcam plc., Biocare
Medical, LLC, and Biocare Medical, LLC.
Browse Other Healthcare Related
Reports
Population
Health Management Market Research Report- Global Forecast To
2023
Syringe
and Needle Market Research Report - Global Forecast to
2027
About Market Research Future
At Market
Research Future (MRFR), we enable our customers to unravel the complexity of
various industries through our Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services
Contact:
Comments
Post a Comment